October 3, 2014 / 12:27 PM / 3 years ago

BUZZ-Tekmira Pharmaceuticals Corp: Maxim Group raises price target

1 Min Read

** Drug developer's shares up 6.1 pct at $26.59 premarket

** Maxim Group raises price target on Tekmira's U.S.-listed stock to $31 from $23, gives a "buy" rating

** Company announced development milestone, supporting a $1.5 million payment from Monsanto Co

** Company agreed on Jan. 13 to license its delivery technology for use by Monsanto's agricultural applications

** Of five analysts covering Tekmira stock, three have "strong buy" ratings and two have "buy" ratings

** Median price target on stock is $25, according to Thomson Reuters data

** Up to Thursday's close, shares more than tripled in value this year

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below